PA 824

PA 824
IUPAC name

(6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine
Identifiers
CAS number 187235-37-6 Y
PubChem 456199
MeSH PA+824
ChEMBL CHEMBL227875 N
Jmol-3D images Image 1
Properties
Molecular formula C14H12F3N3O5
Molar mass 359.258 g/mol
 N (verify) (what is: Y/N?)
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
Infobox references

PA 824 is an experimental anti-tuberculosis drug.[1][2]

References

  1. ^ Ginsberg AM, Laurenzi MW, Rouse DJ, Whitney KD, Spigelman MK (September 2009). "Safety, tolerability, and pharmacokinetics of PA-824 in healthy subjects". Antimicrob. Agents Chemother. 53 (9): 3720–5. doi:10.1128/AAC.00106-09. PMC 2737845. PMID 19528280. http://aac.asm.org/cgi/pmidlookup?view=long&pmid=19528280. 
  2. ^ Stover CK, Warrener P, VanDevanter DR, et al (2000). "A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis". Nature 405 (6789): 962–6. doi:10.1038/35016103. PMID 10879539. 

See also